Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2025-12-30 @ 11:35 AM
Study NCT ID:
NCT05008003
Status:
UNKNOWN
Last Update Posted:
2022-04-04
First Post:
2021-08-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Vit D3 for Early Symptoms of COVID-19
Sponsor:
Ayub Teaching Hospital
Organization:
Study Overview
Official Title:
Vit D3 Adjuvant Therapy for Early Mild Symptoms of COVID-19
Status:
UNKNOWN
Status Verified Date:
2022-03
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is aimed to investigate the treatment vitamin D3 as complementary therapy with routine care for early mild symptoms of COVID-19 in outpatients setting.
Detailed Description:
There is currently no specific early-stage therapeutic treatment available for COVID-19.
Vitamin D3 is a strong antioxidant, and anti-inflammatory/immunomodulatory agent.
The present study is aimed to investigate the treatment benefits of vitamin D3 as add-on therapy to the routine care for early mild symptoms of COVID-19 infection in outpatients setting.
Vitamin D3 is a strong antioxidant, and anti-inflammatory/immunomodulatory agent.
The present study is aimed to investigate the treatment benefits of vitamin D3 as add-on therapy to the routine care for early mild symptoms of COVID-19 infection in outpatients setting.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: